ATE294573T1 - Verwendung von sibutramin oder dessem derivat zur behandlung von schlafstörungen - Google Patents

Verwendung von sibutramin oder dessem derivat zur behandlung von schlafstörungen

Info

Publication number
ATE294573T1
ATE294573T1 AT00918094T AT00918094T ATE294573T1 AT E294573 T1 ATE294573 T1 AT E294573T1 AT 00918094 T AT00918094 T AT 00918094T AT 00918094 T AT00918094 T AT 00918094T AT E294573 T1 ATE294573 T1 AT E294573T1
Authority
AT
Austria
Prior art keywords
sibutramin
derivative
treatment
sleep disorders
snoring
Prior art date
Application number
AT00918094T
Other languages
English (en)
Inventor
Sharon Crawford Cheetham
David John Heal
Carl M Mendel
Timothy B Seaton
Steve P Weinstein
Anton Safer
Original Assignee
Abbott Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg
Application granted granted Critical
Publication of ATE294573T1 publication Critical patent/ATE294573T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Harvester Elements (AREA)
  • Fluid-Pressure Circuits (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT00918094T 1999-03-19 2000-03-17 Verwendung von sibutramin oder dessem derivat zur behandlung von schlafstörungen ATE294573T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12518599P 1999-03-19 1999-03-19
PCT/US2000/007177 WO2000056314A1 (en) 1999-03-19 2000-03-17 Method of treating sleep apnoea

Publications (1)

Publication Number Publication Date
ATE294573T1 true ATE294573T1 (de) 2005-05-15

Family

ID=22418567

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00918094T ATE294573T1 (de) 1999-03-19 2000-03-17 Verwendung von sibutramin oder dessem derivat zur behandlung von schlafstörungen

Country Status (26)

Country Link
US (1) US6365631B1 (de)
EP (1) EP1169029B1 (de)
JP (1) JP2003521469A (de)
KR (1) KR100682291B1 (de)
CN (1) CN1161114C (de)
AT (1) ATE294573T1 (de)
AU (1) AU773489B2 (de)
BG (1) BG106001A (de)
BR (1) BR0009080A (de)
CA (1) CA2367022A1 (de)
CZ (1) CZ298293B6 (de)
DE (1) DE60019914T2 (de)
DK (1) DK1169029T3 (de)
ES (1) ES2244420T3 (de)
HK (1) HK1044462B (de)
HU (1) HUP0200501A3 (de)
IL (2) IL145244A (de)
MX (1) MXPA01009464A (de)
NO (1) NO20014475L (de)
NZ (1) NZ514014A (de)
PL (1) PL359467A1 (de)
PT (1) PT1169029E (de)
SI (1) SI1169029T1 (de)
SK (1) SK285308B6 (de)
WO (1) WO2000056314A1 (de)
ZA (1) ZA200107678B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6974838B2 (en) 1998-08-24 2005-12-13 Sepracor Inc. Methods of treating or preventing pain using sibutramine metabolites
US6476078B2 (en) 1999-08-11 2002-11-05 Sepracor, Inc. Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US6399826B1 (en) 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
US6610887B2 (en) 2001-04-13 2003-08-26 Sepracor Inc. Methods of preparing didesmethylsibutramine and other sibutramine derivatives
PL375032A1 (en) * 2002-10-05 2005-11-14 Hanmi Pharm.Co, Ltd. Pharmaceutical composition comprising crystalline sibutramine methanesulfonate hemihydrate
US20050131074A1 (en) * 2003-08-04 2005-06-16 Beckman Kristen M. Methods for treating metabolic syndrome
US20050228052A1 (en) * 2004-01-29 2005-10-13 Barberich Timothy J Methods of treating, preventing and managing a sleep disorder using (S)-didesmethylsibutramine
DE602005018763D1 (de) * 2004-02-18 2010-02-25 Sepracor Inc Dopamin-agonisten-kombinationstherapie mit sedativa zur verbesserung der schlafqualität
KR100627687B1 (ko) * 2005-04-20 2006-09-25 주식회사 씨티씨바이오 시부트라민 유리염기 함유 조성물 및 이의 제조방법
AU2007322477A1 (en) * 2006-11-22 2008-05-29 Sk Chemicals Co., Ltd. Inclusion complex of sibutramine and beta-cyclodextrin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
IE61928B1 (en) * 1988-11-29 1994-11-30 Boots Co Plc Treatment of obesity
US5356934A (en) * 1990-03-29 1994-10-18 Eli Lilly And Company Selected serotonin subtype receptor agonist to treat sleep apnea
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment

Also Published As

Publication number Publication date
IL145244A0 (en) 2002-06-30
HK1044462B (zh) 2006-03-03
WO2000056314A1 (en) 2000-09-28
SI1169029T1 (sl) 2005-12-31
HUP0200501A2 (en) 2002-08-28
KR100682291B1 (ko) 2007-02-15
SK285308B6 (sk) 2006-10-05
IL145244A (en) 2006-12-10
EP1169029A1 (de) 2002-01-09
BG106001A (en) 2002-06-28
DK1169029T3 (da) 2005-08-29
NO20014475L (no) 2001-11-14
CZ20013280A3 (cs) 2002-07-17
DE60019914T2 (de) 2006-05-04
AU3896800A (en) 2000-10-09
CN1161114C (zh) 2004-08-11
CA2367022A1 (en) 2000-09-28
ES2244420T3 (es) 2005-12-16
IL177626A0 (en) 2006-12-31
PT1169029E (pt) 2005-08-31
MXPA01009464A (es) 2004-03-19
NO20014475D0 (no) 2001-09-14
DE60019914D1 (de) 2005-06-09
SK13382001A3 (sk) 2002-04-04
PL359467A1 (en) 2004-08-23
NZ514014A (en) 2004-02-27
HUP0200501A3 (en) 2004-03-29
BR0009080A (pt) 2002-02-13
ZA200107678B (en) 2003-06-18
EP1169029A4 (de) 2004-01-21
US6365631B1 (en) 2002-04-02
EP1169029B1 (de) 2005-05-04
KR20010113847A (ko) 2001-12-28
AU773489B2 (en) 2004-05-27
CN1356897A (zh) 2002-07-03
JP2003521469A (ja) 2003-07-15
CZ298293B6 (cs) 2007-08-15
HK1044462A1 (en) 2002-10-25

Similar Documents

Publication Publication Date Title
IL177626A0 (en) Pharmaceutical compositions for treating sleep apnoea
DE60039508D1 (de) Methoden zur behandlung der essstörungen
NO20052755D0 (no) Krystallmodifikasjon av et N-fenyl-2-pyrimidinaminderivat, fremgangsmate for dens fremstilling og dens anvendelse.
NO20021328L (no) Pyrazolopyrimidier som terapeutiske midler
DE60226729D1 (de) Hydroxyalkylaminderivate als beta-secretase-inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten
NO20052698L (no) 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gasatrintestinale lidelser.
NO991425D0 (no) Medisinsk behandling
WO2000056315A8 (en) Treatment of pain
DE60117122D1 (de) Verwendung von mirtazapin zur behandlung von schlafstörungen
MXPA01009461A (es) Tratamiento de osteoartritis.
MXPA01009463A (es) Tratamiento de hernia hiatial.
NO20053612L (no) 1,2,4-triaminobenzenderivater nyttige for behandling av forstyrrelser i sentralnervesystemet
DE60305460D1 (de) Verwendung von 4-(4-methylpiperazin-1-ylmethyl)-n 4-methyl-3-(4-pyridin-3-yl) pyrimidin-2-ylamino) phenyl benzamid zur behandlung von seminomen
TH18470B (th) อนุพันธ์เมลาโทนินสำหรับใช้ในการรักษาความผิดปกติของการหลับ

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1169029

Country of ref document: EP

REN Ceased due to non-payment of the annual fee